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Introduction
This study is a continuation of our previous research 
on increasing the dissolution and bioavailability 
of andrographolide self-nanoemulsifying (ASNE). 
The previous study showed that ASNE (15 mg/mL) 
demonstrated 12.0 ± 0.2 nm, -46.3 ± 4.2 mV, and 
99.4% of particle size, zeta potential, and transmittance, 
respectively. This formulation is thermodynamically 
stable and significantly improved dissolution as opposed 
to andrographolide (AND) suspension. The ASNE also 
improves the AND bioavailability in rabbit plasma with 
AUC value enhanced by 1.2-fold, C
max increased by 1.26-
fold, and Tmax decreased by 1.72-fold when compared to 
AND suspension.1 
We expect to examine the correlation between an 
increase in pharmacokinetic profiles previously studied 
and the antidiabetic activity of ASNE. Diabetes mellitus 
(DM) is a common metabolic disorder characterized 
by chronic hyperglycemia due to the effects of insulin 
secretion or insulin action. It currently affects 463 million 
people worldwide but this figure is estimated to reach up 
to 578 million by 2030. Another study also reported that 
8.3% people suffer from DM to date with the number 
predicted to increase to more than 700 million globally by 
2045.2-4 Apart from the use of insulin or oral hypoglycemic, 
other effective methods for treating diabetes have yet 
to be developed. Meanwhile, the initial symptom in the 
pathogenesis of diabetes is a decrease in the beta-cell 
function, which plays a role in causing type-2 diabetes 
mellitus (T2DM). Therefore, it is necessary to restore cell 
functions to prevent T2DM.5 
Self-nanoemulsifying (SNE) is a method to improve 
the solubility and bioavailability of drugs, such as AND,1 
lovastatin,6 nisoldipine,7 and glipizide.8 SNE has also been 
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• Pancreatic beta cells
Abstract
Purpose: Insulin resistance is a characteristic of non-insulin-dependent diabetes mellitus 
associated with obesity and caused by the failure of pancreatic beta cells to secrete sufficient 
amount of insulin. Andrographolide (AND) improves beta-cell reconstruction and inhibits fat-
cell formation. This research aimed to improve the delivery of water-insoluble AND in self-
nanoemulsifying (ASNE) formulation, tested in streptozotocin (STZ)-induced diabetic rats and 
3T3-L1 preadipocyte cells. 
Methods: A conventional formulation of AND in suspension was used as a control. The 
experimental rats were orally administered with self-nanoemulsifying (SNE) and suspension of 
AND for 8 days. Measurements were performed to evaluate blood glucose levels in preprandial 
and postprandial conditions. Immunohistochemistry was used to assess the process of islet beta 
cell reconstruction. In vitro study was performed using cell viability and adipocyte differentiation 
assay to determine the delivery of AND in the formulation.
Results: ASNE lowered blood glucose levels (day 4) faster than AND suspension (day 6). The 
histological testing showed that ASNE could regenerate pancreatic beta cells. Therefore, ASNE 
ameliorated pancreatic beta cells. The in vitro evaluation indicated the inhibition of adipocyte 
differentiation by both AND and ASNE, which occurred in a time-dependent manner. ASNE 
formulation had better delivery than AND.
Conclusion: ASNE could improve the antidiabetic activity by lowering blood glucose levels, 
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reported to be able to increase the anti-cancer activity of 
genistein9 and the antifungal activity of orally administered 
nystatin.10 Compared with the natural forms, solid SNE of 
polypeptide-k tested in vivo through oral administration 
to streptozotocin (STZ)-induced rats provided a better 
antidiabetic activity.11
AND is a bioactive compound found in the 
Andrographis paniculata Nees plant with antidiabetic12 
and antioxidant activities.13 AND is poorly soluble in 
water, which is associated with low bioavailability in 
its oral administration.1 The administration of oral 
AND can lower plasma glucose levels in STZ-induced 
diabetic rats, but the activity of which depends on the 
dose administered14 and the treatment applied.15 A 
compound with low water solubility generally has limited 
absorption and bioavailability that is usually controlled 
by the dissolution rate of the drug in the gastrointestinal 
tract. Therefore, efforts need to be made to increase the 
solubility. In addition, low bioavailability influences 
the pharmacological effects of drug compounds.16 
AND significantly impedes adipocyte differentiation 
induced by adipogenic agents and multiple daily doses 
of insulin (MDI) as well as inhibits adipogenesis-related 
transcription factor, peroxisome proliferator-activated 
receptor (PPAR), and the expression of PPARγ-targeted 
genes.17 AND has also been proven to raise glucose uptake 
depending on the time and dose in 3T3-L1 cells.18 
The abovementioned data suggest that preparations in 
the form of SNE can improve the pharmacological effects 
of drug compounds. However, although ASNE preparation 
has been investigated to increase the bioavailability, studies 
of its antidiabetic activities have never been reported. This 
study therefore aimed to examine the SNE preparation of 
AND in vivo using rats with STZ-induced diabetes and in 
vitro using 3T3-L1 adipocyte cells.
Materials and Methods
Materials
AND was extracted and isolated from Andrographis 
paniculata collected from traditional markets in Yogyakarta 
(Indonesia) based on previous research.15 Capryol 90 was 
provided by Gattefose (Saint-Priest, France), Tween 20 
and polyethylene glycol (PEG) 400 were obtained from 
Brataco (Yogyakarta, Indonesia), and STZ was purchased 
from Sigma-Aldrich (Missouri, USA). A colorimetric 
method (GOD-PAP) was used to measure glucose levels, 
and the antibodies used in the determination of the 
insulin expression were primary anti-insulin antibody 
from Santa Cruz Biotechnologies (California, USA) 
and secondary chicken anti-gout IgG antibody from 
Invitrogen (California, USA). Victoria Blue, hematoxylin, 
and eosin were purchased from Sigma Chemical Co. 
(California, USA), and 3T3-L1 preadipocytes were 
obtained from American Type Cell Culture Collection 
(Virginia, USA). Other materials included Dulbecco’s 
Modified Eagle’s Medium from Sigma (California, USA), 
fetal bovine serum and penicillin-streptomycin from 
Gibco (Maryland, USA), as well as 3-[4,5-dimethylthiazol-
2-yl]-2,5-diphenyl-tetrazoliumbromide (MTT) from 
Calbiochem (Darmstadt, Germany).
Preparation of AND-loaded SNE
SNE was prepared using Capryol 90 (oil phase), Tween 20 
(surfactant), and PEG 400 (cosurfactant) at a ratio of 1:3:1. 
ASNE was obtained by mixing SNE with 15 mL of AND, 
based on a previously reported procedure.1
Animal study
Animals
Twenty-four adult’s male Wistar rats with a body weight 
ranging from 200 g to 250 g at the beginning of the 
experiment were used in this current study. All of the 
experimental animals were placed in a standard-size cage 
at a temperature of 25°C under conditions of 12 h of light 
and 12 h of dark with the natural food and distilled water 
provided ad libitum.
Preparation of STZ-induced type 2 diabetic rats
Neonatal rats were administered with STZ dissolved in 
citrate buffer (pH 4.5) and injected intraperitoneally at a 
dose of 90 mg/kg BW, whereas neonatal control rats were 
given an intraperitoneal injection with the same amount 
of citrate buffer solution. Two and a half months after 
injection, STZ-induced rats were selected for the study by 
setting the levels of blood glucose before and after food 
administration. Rats with a glucose level of more than 180 
mg/dL were considered to have diabetes.13,19,20
Experimental design
Pharmacological tests were performed on STZ-induced 
Wistar rats at birth, and after the age of 2.5 months, 
they were treated in line with the experimental design 
presented in Table 1. The medicine was administered for 
8 days, and preprandial blood samples were taken on day 
0, 2, 4, 6, and 8 after a 10 h fast. Two hours after feeding, 
blood samples were retaken to determine postprandial 
glucose levels.
Determination of blood glucose levels
As previously explained, on day 0, 2, 4, and 8, preprandial 
Table 1. Experimental design of pharmacological test (N = 6)
Groups Animals Treatment
I
Control rats injected with 
0.1 mL citrate buffer
Distilled water (vehicle) given twice 
a day orally
II Normal rats
15 mg/mL AND suspension given 
twice a day orally
III
Neonatal rats induced by 
STZ
15 mg/mL ASNE given twice a day 
orally
IV
Neonatal rats induced by 
STZ
15 mg/mL AND suspension given 
twice a day orally
Abbreviations: STZ, streptozotocin; AND, andrographolide; ASNE, 
andrographolide in self-nanoemulsifying.
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blood samples were taken after a 10 h fast, and postprandial 
blood samples were taken 2 h after feeding. As much 
as 0.5 mL of blood was obtained through the eye vein 
(retro-orbital sampling). Serum was obtained after the 
centrifugation of blood samples at 3500 rpm for 15 min, 
and serum glucose was analyzed in spectrophotometry 
using the glucose oxidase-peroxidase method with a 
commercial biochemical diagnostic reagent kit (Glucose, 
GOD-PAP) (R1).13,19,20 The blank, standard, and samples 
were incubated at 37°C for 15 min, followed by the reading 
of solution absorbance using a UV/Vis spectrophotometer 
at a wavelength of 546 nm.
Histological observation of the islets of Langerhans and 
pancreatic beta cells
The rats were sacrificed at the end of the treatment. The 
pancreases of control rats and treated rats were taken and 
affixed in 10% formalin and phosphate buffer pH 7.5 for 
24 h. The tissue was embedded in paraffin and sliced into 
sections of the desired thickness (4 μm), and the paraffin 
was then removed in xylene and dehydrated using a series 
of alcohol concentrations (70%, 80%, 90%, 95%, and 
99%). The slices were then stained using hematoxylin 
and eosin (HE) or 1% Victoria Blue (pH 0.3) to evaluate 
the islets of Langerhans and pancreatic beta cells. The 
slides were cleaned with xylene, affixed using a mounting 
medium, and examined under a light microscope. 
Pancreatic beta cells were identified and detected in each 
slide to be analyzed.13,19,20 Preparation of the pancreas 
using HE staining was performed to observe the 
presence of pancreatic islets of Langerhans qualitatively. 
The pancreatic islets of Langerhans were quantitatively 
calculated to determine the average number of the islets of 
Langerhans. In addition, preparation of the pancreas with 
Victoria Blue staining was also performed to measure the 
average area of the islets of Langerhans and the percentage 
of pancreatic beta cells compared with the total number of 
cells in the islets of Langerhans.
Immunohistochemistry of pancreatic insulin
Another part of the pancreas was prepared with 4% 
formaldehyde in phosphate-buffered saline (PBS) for 
a minimum of 2 h. The tissue was dried in alcohol at a 
specific concentration and cleaned using a xylol cleaning 
agent. After being embedded in paraffin, 2–3 μm slices 
were obtained using a rotary microtome. The tissue was 
then attached to a slide, and the endogenous peroxidase 
activity in the tissue was inhibited using 3% H2O2 in 
methanol for 15 min, followed by washing with distilled 
water. One part of the tissue was then incubated with 20% 
horse serum for a minimum of 10 min to prevent non-
specific binding. Another part of it was incubated at a 
room temperature with primary antibody to rat insulin 
by diluting it at 1:250 for 1 h and later with peroxidase-
conjugated secondary antibody at 1:500 dilution for 1 h. 
The expression of pancreatic insulin could be visualized 
after incubation in a substrate for 15 min. The tissue was 
stained with hematoxylin for 30 min, dried with alcohol 
and xylol, and then affixed to a coverslip. The slides were 
then evaluated using a light microscope.13,19,20
In vitro study
Cell viability assay
Cell viability assay was performed using MTT21 with 
modification. The 3T3-L1 cells (Zen-Bio Inc., USA) were 
grown in Dulbecco’s modified Eagle’s medium (DMEM; 
Nacalai Tesque Inc., Japan) supplemented with 10% FBS 
and 1% antibiotics. Cells were seeded at a density of 2 × 
105 cells/mL and incubated at 37°C with 5% CO2. After 
reaching confluence, the cells were treated with samples 
and further incubated for 48 h. Once the treatment period 
was over, MTT solution (5 mg/mL) was added to each well, 
and the plate was incubated at 37°C with 5% CO2 for 4 h. 
Next, the supernatant was removed, and 100 µL of DMSO 
was added to each well after which spectrophotometric 
absorbance was measured at a wavelength of 570 nm with 
a reference wavelength of 630 nm. The 50% reduction in 
cell number relative to the control (IC50) was established 
by extrapolation from a graph of the experimental data.
Adipocyte differentiation (adipogenesis) assay
Cells were seeded at a density of 2 × 105 cells/mL and 
incubated until they reached confluence. In two days of 
post-confluence (day 0), cells were induced to differentiate 
using an induction medium containing dexamethasone, 
3-isobutyl-1-methylxanthine (IBMX), and insulin/
samples (Table 2). Insulin treatment (1 µg/mL) was used 
as a control of the experiment. On day 2, the medium was 
changed into insulin and replaced every other day until 
day 8. After completing the differentiation course, cells 
were washed with PBS and fixed using 10% formalin for 
1 h. Then, cells were rewashed with PBS and stained with 
Oil Red O for another hour. The cells were finally washed 
with distilled water and analyzed qualitatively using 
an inverted microscope (Leica, Germany). Meanwhile, 
quantitative analysis was performed by extracting the stain 
from the cells using isopropanol, and spectrophotometric 
absorbance was measured at 520 nm.22
Statistical analysis
All statistical analyses were performed using Microsoft 
Office Excel 2010. The quantitative data calculations of 
HE and Victoria Blue staining, the percentage of beta cells 
with insulin expression, and adipocyte differentiation were 
expressed as mean ± SEM. One-way analysis of variance 
was used for the statistical analysis. A P value of less than 
0.05 was considered as indicating a significant difference.
Results and Discussion
Animal study
Determination of blood glucose levels
The results of preprandial blood glucose level measurement 
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presented in Figure 1 show that control rats administered 
with solvents and normal rats administered with AND 
suspension had normal blood glucose levels (less than 160 
mg/dL) during 8 days of treatment. The administration of 
ASNE reduced the blood glucose levels to normal on day 
4, whereas AND suspension decreased the blood glucose 
levels to normal on day 6. The postprandial blood glucose 
levels described in Figure 2 indicate the same results as 
those in the preprandial in terms of the normalization of 
blood glucose levels, which occurred on day 4 in ASNE 
and day 6 in AND suspension.
Hyperglycemia induced by STZ has been widely used as 
an experimental model to study hypoglycemic activities. 
The mechanism of diabetes caused by STZ involves the 
selective destruction of pancreatic beta cells that causes 
hypoinsulinemia, thus resulting in hyperglycemia and 
reduced glucose uptake as the main characteristics of the 
disease.23,24 ASNE could reduce the postprandial blood 
glucose levels on days 2, 4, 6, and 8 compared with AND 
suspension (P < 0.05) as shown in Figure 2. In general, 
ASNE could provide a more immediate effect to normalize 
blood glucose levels compared with AND suspension. 
The pharmacokinetic profile supports the results of blood 
glucose level measurement as previously reported1 in 
which the time taken by ASNE to reach the maximum drug 
concentration in blood (Tmax) was 1.72-fold faster than 
that by AND suspension. Therefore, the pharmacological 
effects of ASNE are more immediate than those of AND 
suspension. A study of the correlation between the 
pharmacokinetic and pharmacological effects on diabetes 
has also proven that insulin self-nano emulsifying drug 
delivery system (SNEDDS)  produced 2.7- and 3.4-fold 
enhancement in the relative bioavailability and glucose 
reduction.25 Glipizide solid SNEDDS formulation showed 
increases in Cmax (3.4-fold) and AUC0-12h (2.7-fold) and a 
decrease in the plasma glucose level by 1.3-, 1.3-, and 2.9-
fold compared with the pure drug.26
Histological observation of the islets of Langerhans and 
pancreatic beta cells
Observation of the islets of Langerhans was carried out 
with HE staining, and pancreatic beta cell observation 
used the Victoria Blue staining. The results of histological 
observation of the islets of Langerhans with HE staining 
are shown in Figure 3 while the histopathological findings 
of pancreatic beta cells with Victoria Blue staining are 
presented in Figure 4.
Quantitative calculations from the HE and Victoria 
Blue staining for the number of the islets of Langerhans, 
the area of the islets of Langerhans, and the percentage of 
pancreatic beta cells compared with the total number of 
cells in the islets of Langerhans are presented in Table 3.
Table 2. Adipocyte differentiation protocol 

















4 – 8 Complete DMEM Complete DMEM Complete DMEM
10 Oil Red O Staining
Abbreviations: DMEM, Dulbecco's modified Eagle's medium; IBMX, 3-isobutyl-1-methylxanthine.
Figure 1. Preprandial blood glucose levels of the control rats 
(A), normal rats receiving andrographolide (AND) suspension 
(B), neonatal rats induced by streptozotocin (STZ) receiving 
andrographolide in self-nanoemulsifying, ASNE (C), and neonatal 
rats induced by STZ receiving AND suspensions (D). The variations 
of the average are shown as SD, with three times repetition.
Figure 2. Postprandial blood glucose levels of the control rats 
(A), normal rats receiving andrographolide (AND) suspension 
(B), neonatal rats induced by streptozotocin (STZ) receiving 
andrographolide in self-nanoemulsifying, ASNE (C), and neonatal 
rats induced by STZ receiving AND suspension (D). The variations 
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Table 3 showed that ASNE (C) and AND suspension 
(D) were associated with different numbers of the islets 
of Langerhans, 5.75 ± 2.36 and 5.25 ± 1.50, respectively 
(P < 0.05), whereas in the initial condition (negative 
control, E), the number was 2.75 ± 1.26. The area of the 
islets of Langerhans also increased (P < 0.05) from 274.307 
± 29.7 µm in the negative control (E) to 387.161 ± 64.00 
and 681.929  157.41 µm in ASNE (C) and AND suspension 
(D), respectively. These findings prove that ASNE and 
AND suspension could increase the number and area of 
the islets of Langerhans. They were also able to increase 
the percentage of beta cells (P < 0.05) from 40.52 ± 4.56% 
in the negative control (E) to 61.70 ± 1.12% and 65.49 ± 
0.48%, respectively. 
The area of the islets of Langerhans and the percentage 
of pancreatic beta cells in AND suspension (D) are higher 
than in ASNE (C) as presented in Table 3. AND suspension 
is prepared by dissolving AND in a suspending agent 
while ASNE is produced by dissolving AND in an oil, 
surfactant and cosurfactant as the vehicle, but ASNE will 
spontaneously disperse when dissolved in water. ASNE 
plays a role in accelerating the repair effect on the islets of 
Langerhans and pancreatic beta cells. This finding showed 
that AND suspension could improve the area of the islets 
of Langerhans and pancreatic beta cells better than ASNE. 
However, the effects remain the same as both can produce 
pancreatic beta cells, normally, with the percentage 
exceeds 60%.
The number of beta cells determines the area of the 
Islets of Langerhans in that location. Rupture of the Islets 
of Langerhans and decreased function of pancreatic 
beta-cells cause diabetes. In the abovementioned model, 
STZ reaches beta cells through a mechanism of glucose 
transport. STZ has been reported to cause DNA alkylation 
by releasing high concentrations of nitric oxide and 
nitrosourea, thus causing aconitase inhibition. Insulin 
resistance or insulin deficiency (T2DM) in animal models 
induced by STZ depends on several factors, such as STZ 
dose, animal age, and animal strain.19,27 The use of STZ-
induced type-2 diabetic experimental animals, such 
as neonatal rats aged 2 days, with damaged pancreatic 
beta cells through regeneration remains possible. Rats 
experience hyperglycemia due to insulin deficiency. 
The presence of DM in experimental animals will be 
observable during their selection for treatment based 
on the blood glucose levels that exceed the average. The 
maximum glucose level of normal rats is 160 mg/dL, 
whereas the selected rats with DM had a blood glucose level 
of more than 180 mg/dL. Similarly, in the experiments with 
indolizine derivatives and capsaicinoids, these compounds 
lowered blood glucose levels in STZ-induced diabetic rats 
while also selectively damaging pancreatic beta cells via 
reactive oxygen species. The administration of STZ to rats 
will damage the pancreatic necrosis of the beta cells in the 
islets of Langerhans and also impair the function of the 
Figure 3. Observation of the islets of Langerhans (L) with HE staining 
(400x magnification) of the normal rats (A), normal rats receiving 
andrographolide (AND) suspension (B), diabetic rats receiving 
andrographolide in self-nanoemulsifying, ASNE (C), diabetic rats 
receiving AND suspension (D), and diabetic rats as the negative 
control (E).
Figure 4. Observation of the pancreatic beta cells with Victoria 
Blue staining (400x magnification) of the normal rats (A), normal 
rats receiving andrographolide (AND) suspension (B), diabetic 
rats receiving andrographolide in self-nanoemulsifying, ASNE (C), 
diabetic rats receiving AND suspension (D), and diabetic rats as the 
negative control (E).
Syukri et al
Advanced Pharmaceutical Bulletin, 2021, Volume 11, Issue 1176
pancreas. This condition ultimately results in diabetes, 
which causes an increase in plasma glucose levels (because 
it decreases plasma insulin) and weight loss.28,29 It was also 
reported that the mechanism of the antidiabetic activity of 
a natural compound named corilagin occurs via increased 
utilization of peripheral glucose by skeletal muscles apart 
from a beta-cell stimulation.30
The improvement of insulin sensitivity is a critical 
approach in the management of T2DM; it was reported 
that AND derivatives ameliorate insulin sensitivity in 
rats.31 Observation of the islets of Langerhans using 
HE staining also showed that in normal rats (A) and 
normal rats given AND suspension (B) without induced 
STZ, the islets of Langerhans appeared normal, without 
inflammation, degeneration, or necrosis. Diabetic rats 
given ASNE (C), and AND suspension (D) showed normal 
islets of Langerhans and no inflammation, congestion, 
degeneration, or necrosis (Figure 3). In untreated diabetic 
rats (E), the islets of Langerhans were rare, atrophic, and 
relatively small in size, whereas some cells in them were 
normal while some exhibited degeneration and necrosis 
(Figure 3). The data presented above demonstrate 
that AND provided a repairing effect for the islets of 
Langerhans in the pancreas of rats.
It has been proven that ASNE and AND suspension 
could reduce blood glucose levels through improvements 
in pancreatic insulin, but ASNE had a more immediate 
effect than AND suspension. STZ-induced diabetic rats 
had significantly decreased blood glucose levels with the 
administration of ASNE and AND suspension. Compared 
with AND suspension, ASNE showed a faster process in 
decreasing blood glucose levels. These findings are likely 
related to the higher bioavailability of ASNE compared 
with that of AND suspension in terms of the shorter 
time to achieve maximum drug concentration in blood 
(Tmax). The blood-glucose-lowering effect of ASNE and 
AND suspension is likely caused by the stimulation of 
beta cells in the islets of Langerhans, which results in 
more insulin release. Increased plasma insulin levels 
reinforce this finding in diabetic rats treated with ASNE 
and AND suspension, and there is also an increase in 
the number of immunoreactive cells that secrete insulin 
in many parts of the pancreatic islets as indicated by 
the immunohistochemical analysis.23 Another possible 
mechanism of blood glucose level reduction is through 
potentiating the effects of plasma insulin by increasing 
pancreatic insulin secretion from the cells of the islets of 
Langerhans or their release from the bonds.32 
Immunohistochemistry of pancreatic beta cells
The staining process for immunohistochemistry testing 
followed the preparation method for HE staining blocks, 
and observation of insulin expression on the islets of 
Langerhans was performed using insulin antibodies. 
The results of pancreatic insulin immunohistochemical 
analysis are presented in Figure 5. 
Preparation of the pancreas with immunohistochemistry 
of insulin antibodies was performed with the aim of 
counting the beta-cells with brown cytoplasm, which 
showed insulin expression, in comparison with all of the 
non-brown cells in the islets of Langerhans. The results 
of the quantitative immunohistochemical analysis are 
presented in Table 4.
Table 4 showed that ASNE (C) and AND suspension 
(D) could increase (P < 0.05) the number of cells with 
insulin expression compared with the negative control 
(E), initially from 14.70 ± 4.95 to 47.70 ± 5.52 and 41.50 
6.36. Other cells also showed that ASNE (C) and AND 
suspension (D) could also increase their percentages 
(P < 0.05) compared with the negative control (E), from 
15.52 ± 5.77% to 60.43 ± 2.56% and 39.05  1.02%.
Pancreatic histopathological investigation in diabetic 
rats induced by STZ showed histological changes in the 
pancreas. This damage occurs because STZ attacks the 
pancreatic beta cells through glucose transporter 2, which 
results from the damage of beta cells by DNA alkylation. 
The production of superoxide radicals also causes this 
damage with the help of xanthine oxidase and free 
radicals of nitric oxide. Free radicals make a significant 
contribution to the development of DM as such, which 
causes damage to beta cells.33,34 Treatment with AND may 
protect the cells from free radicals caused by STZ. Zhang 
reported that AND increases insulin and prevents the loss 
of beta cells and their dysfunction in soleus muscles.35
In vitro study
Effect of SNEEDS on adipocyte differentiation
MTT assay was conducted to evaluate the cytotoxic 
activity of the emulsion on cultured cells (Figure 6). It was 
found that, at 100 µg/mL, the emulsion had no cytotoxic 
Table 3. Quantitative calculations in Hematoxylin-Eosin (HE) and Victoria Blue staining to count the number of the islets of Langerhans, the area of the islets of 
Langerhans, and the percentage of pancreatic beta cells (n = 3)
Code Treatment
The number of islets of 
Langerhans
The area of islets of Langerhans 
(µm2)
The percentage of pancreatic beta 
cells (%)
A Normal rats 9.00 ± 1.41* 868,761 ± 135.20* 69.83 ± 1.79*
B Normal rats receiving AND suspension 7.50 ± 1.29* 623,046 ± 13.99* 66.12 ± 8.6*
C Diabetic rats receiving ASNE 5.75 ± 2.36* 387,161 ± 64.00* 61.70 ± 1.12*
D Diabetic rats receiving AND suspension 5.25 ± 1.50* 681,929 ± 157.41* 65.49 ± 0.48*
E Diabetic rats as the negative control 2.75 ± 1.26 274,307 ± 29.7 40.52 ± 4.56*
* Significantly different from the negative control (P < 0.05)
Abbreviations: AND, andrographolide; ASNE, andrographolide in self-nanoemulsifying.
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effect on the cells. This data was used as the baseline 
concentration for the adipocyte differentiation assay. As 
shown in Figures 7 and 8, both AND suspension and 
ASNE inhibited the formation of mature adipocytes in a 
dose-dependent manner.
To understand the critical stage of adipogenesis 
inhibition by AND suspension (Figure 7), the preparation 
was added to the culture medium in 2 days of post-
confluence (day 0), and cells were induced to differentiate 
using an induction medium containing dexamethasone, 
IBMX, and insulin/or AND (3.13, 6.25 and 12.5 μg/
mL). On day 2, the medium was changed into an insulin 
medium and replaced every 2 days until day 8. After 
completing the differentiation course, cells were washed 
with PBS and fixed using 10% formalin for 1 h. Then, 
cells were rewashed with PBS and stained with Oil Red 
O for another hour. Using the same method (Figure 8), 
ASNE preparation was added in 2 days of post-confluence 
(day 0), and cells were induced to differentiate using an 
induction medium containing dexamethasone, IBMX, 
and insulin/or ASNE (0.19, 0.38 and 0.75 μg/mL). This 
finding showed that the anti-adipogenic effect of ASNE 
at a low dose (0.75 μg/mL) is similar to that of AND 
suspension at a dose of 3.13 μg/mL, thus indicating that 
ASNE is approximately 4 times more effective than AND 
suspension.
In the in vitro study, AND tended to have an anti-obesity 
effect on 3T3-L1 adipocytes. Another study previously 
showed that AND significantly inhibited the differentiation 
of preadipocytes, which was induced by adipogenic agents 
and MDI.36 Adipose tissue dysfunction causes metabolic 
syndrome involving insulin resistance and type-2 diabetes. 
Adipose is not only known for its capacity to store excess 
food energy in the form of triglycerides but has also been 
recognized as playing an essential role in the control of 
energy metabolism. Meanwhile, adipocytes are cells 
that can save excess energy in the form of triglycerides, 
and their level of differentiation is closely related to 
obesity.22,37,38 Adipocytes become the main drug target 
for diabetes and metabolic syndrome caused by obesity. 
Obesity itself is caused by the process of fat accumulation 
which can be divided into two main stages: the process 
of differentiation of adipocytes (adipogenesis) and the 
process of fat synthesis (lipogenesis). 
Inhibition is related to a transcription factor, PPARγ, 
Table 4. The number and percentage of beta-cells with insulin expression compared with other cells in the islets of Langerhans (n = 3)
Code Treatment The number insulin of expression The percentage of insulin expression (%)
A Normal rats 79.40  ± 2.55* 78.06 ± 3.09* 
B Normal rats receiving AND suspension 74.98  ± 8.41* 74.98 ± 1.73*
C Diabetic rats receiving ASNE 47.70 ± 5.52* 60.43 ± 2.56*
D Diabetic rats receiving AND suspension 41.50 ± 6.36* 39.05 ± 1.02*
E Diabetic rats as the negative control 14.70 ± 4.95 15.52 ± 5.77
*Significantly different from the negative control (P < 0.05).
Abbreviations: AND, andrographolide; ASNE, andrographolide in self-nanoemulsifying.
Figure 5. Observation of immunohistochemical-stained section 
insulin pancreas (I) (1000x magnification) of the normal rats (A), 
normal rats receiving andrographolide (AND) suspension (B), 
diabetic rats receiving andrographolide in self-nanoemulsifying, 
ASNE (C), diabetic rats receiving AND suspension (D), and diabetic 
rats as the negative control (E).
Figure 6. Effect of different concentrations of andrographolide in self-
nanoemulsifying (ASNE) on cell viability of 3T3-L1 preadipocytes. 
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as well as the expression of PPARγ-targeted genes. When 
comparing the effectiveness of ASNE and AND in the in 
vitro study, it was found that ASNE delivery was twice 
more effective than AND. However, AND also increased 
the glucose uptake in a time- and dose-dependent manner 
in 3T3-L1 cells.17
Conclusion
ASNE formulation could reduce blood glucose levels to 
normal in STZ-induced rats in a faster and more effective 
manner than AND suspension. The decreased blood 
glucose levels to normal occurred on day 4 in ASNE and 
day 6 in AND suspension. Histological tests showed that 
ASNE could regenerate pancreatic beta cells and increase 
insulin expression. In the adipocyte differentiation assay, 
it was demonstrated that the ASNE formulation achieved 
better delivery of AND.
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Figure 7. Effect of andrographolide, AND (3.13, 6.25 and 12.50 
µg/mL) on adipocyte differentiation of 3T3-L1 cells, quantification 
of lipid (top) and intracellular lipid droplet and total lipid content 
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Figure 8. Effect of andrographolide in self-nanoemulsifying, ASNE 
(0.19, 0.38 and 0.75 µg/mL) on adipocyte differentiation of 3T3-
L1 cells, quantification of lipid (top) and intracellular lipid droplet 
and total lipid content with 400x magnification (bottom). * P < 0.05 
when compared with the positive control
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